Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VISMODEGIB vs VOLTAREN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VISMODEGIB vs VOLTAREN: Safety Overview

Metric VISMODEGIB VOLTAREN
Total FAERS Reports 8,135 270
Deaths Reported 864 36
Death Rate 10.6% 13.3%
Hospitalizations 974 52
Average Patient Age 69.6 yrs 66.3 yrs
% Female Patients 39.3% N/A
FDA Approval Date Jan 30, 2012 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A